Anavex Life Sciences Announces the Appointment of Walter E Kaufmann, MD as Chief Medical Officer
NEW YORK, Jan. 02, 2019 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage […]
NEW YORK, Jan. 02, 2019 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage […]
PLEASANTON, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) — Natus Medical Incorporated (NASDAQ: BABY) today announced that the Company will release […]
LOS ANGELES, Jan. 02, 2019 (GLOBE NEWSWIRE) — Nova LifeStyle, Inc. (NASDAQ: NVFY) today responded to a document published by […]
SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) — Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company focused on […]
ENGLEWOOD CLIFFS, N.J., Jan. 02, 2019 (GLOBE NEWSWIRE) — ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company […]
– 50 mg Cohort Completed – – Clinical Update Expected in the Second Quarter of 2019 – SOUTH SAN FRANCISCO, […]
– Trial continues as planned with enrollment target of 350 patients – – Top-line data readout expected in the first […]
NEW YORK, Jan. 02, 2019 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today […]
LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing […]
NEWTON, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that Michael […]